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Abstract
Stroke is an age-related disease. Recovery after stroke is associated with axonal sprouting in 
cortex adjacent to the infarct. The molecular program that induces a mature cortical neuron to 
sprout a new connection after stroke is not known. We selectively isolated neurons that sprout a 
new connection in cortex after stroke and compared their whole-genome expression profile to that 
of adjacent, non-sprouting neurons. This ‘sprouting transcriptome’ identified a neuronal growth 
program that consists of growth factor, cell adhesion, axonal guidance and cytoskeletal modifying 
molecules that differed by age and time point. Gain and loss of function in three distinct functional 
classes showed new roles for these proteins in epigenetic regulation of axonal sprouting, growth 
factor–dependent survival of neurons and, in the aged mouse, paradoxical upregulation of myelin 
and ephrin receptors in sprouting neurons. This neuronal growth program may provide new 
therapeutic targets and suggest mechanisms for age-related differences in functional recovery.
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Stroke is an age-related disease and the leading cause of adult disability. Reorganization of 
motor, sensory and language functions in cortical regions in the brain hemisphere near the 
stroke are the events most closely correlated with behavioral recovery1. Stroke induces 
axonal sprouting and the formation of new patterns of neuronal connections within these 
peri-infarct regions2–4. An understanding of the molecular events that underlie axonal 
sprouting in the adult brain after stroke, and that are affected by age, may identify new 
targets that promote recovery in this disease. Molecular studies of axonal sprouting in CNS 
injury have focused mostly on proteins that inhibit the formation of new connections, such 
as myelin-associated proteins and glial extracellular matrix molecules5,6. However, 
therapies that only block axonal growth inhibitors may not produce maximal axonal 
sprouting and recovery after CNS injury7. Combined therapies that both stimulate a 
neuronal growth state and block axonal growth inhibitors produce more robust axonal 
sprouting and functional recovery after stroke8.
A gene expression program that underlies a neuronal growth state after stroke has not been 
determined. Studies of a molecular neuronal growth program have been limited because 
there has been no way to selectively label and isolate the small subset of cortical neurons 
that undergo axonal sprouting after stroke from the larger population of neurons that do not. 
In contrast, the transcriptional profile of a neuronal growth state has been identified in gene 
expression studies of axonal sprouting in the dorsal root ganglion and retinal ganglion cells 
after injury9–12. Gene expression studies of neurons in cortex contralateral to stroke, some 
of which sprout new spinal connections, have shown activation of an injury-associated 
molecular program8. However, there have been no studies of the molecular mechanisms of 
axonal sprouting in neurons in peri-infarct cortex or of the specific gene expression profile 
of a sprouting neuron after adult CNS injury.
The present studies develop a method to selectively label sprouting neurons in peri-infarct 
cortex after stroke. This approach has the methodological advantages that the sprouting 
neurons are compared to non-sprouting neurons from the same rat, from the same brain 
region and exposed to the same stroke conditions. The results identified a sprouting or 
regeneration transcriptome after stroke that changed with time after injury, differed between 
young and aged rats and mice, and contained molecules that have different mechanistic roles 
in the process of brain reorganization after stroke.
RESULTS
Gene expression profile of sprouting neurons after stroke
Stroke was produced in the whisker (barrel) field of the somatosensory cortex in young adult 
and aged rats13, which induces a region of axonal sprouting in peri-infarct sensorimotor 
cortex2,14. To label neurons that sprout and establish a new projection pattern in peri-infarct 
cortex, we injected two different fluorescent conjugates of the tracer cholera toxin B (CTB) 
into forelimb sensorimotor cortex. CTB back-labels neurons that project to the injection site. 
Alexa 488–CTB was injected at the time of the stroke; 7 or 21 d later Alexa 647–CTB was 
injected at the same site as Alexa 488–CTB, but at two-thirds the volume (Fig. 1a). We used 
for gene expression analysis only those rats with injection sites in which the second tracer 
injection was entirely within the first (Fig. 1b) (n = 21 in total). Neurons that were double-
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labeled from the two tracer injections (Fig. 1c) were those that did not change their 
projection to the injection site after stroke. Neurons that took up only the second tracer (Fig. 
1c) were those that had not had an axonal projection to the injection site at the time of the 
injection of the first tracer15,16, and thus established a new projection pattern after stroke. 
We laser-captured neurons in peri-infarct cortex if they were double-labeled (non-sprouting) 
or were labeled by tracer 2 only (sprouting) (Fig. 1c, Supplementary Discussion and 
Supplementary Fig. 13). Whole-genome expression analysis was used to identify the distinct 
transcriptional profile of a sprouting neuron in peri-infarct cortex after stroke. With a P-
value threshold of < 0.005 and after filtering for a minimum log2-transformed fold change of 
0.2, most differential gene regulation in axonal sprouting after stroke had taken place by day 
7, and more genes were differentially expressed in young adults: in young adult at 7 d, 804 
genes were upregulated and 542 were downregulated; in young adult at 21 d, 572 were 
upregulated and 164 downregulated; in aged adults at 7 d, 384 were upregulated and 237 
downregulated; in aged adults at 21 d, 157 genes were upregulated and 76 downregulated 
(Supplementary Tables 1, 2, 4 and 5). There were substantial differences between those 
genes induced in sprouting neurons in aged versus young adult at each time point. Only 79 
genes were upregulated in common in both aged and young adult at day 7, and 18 genes 
were upregulated in common at day 21 (Supplementary Tables 4 and 5).
We focused further analysis on genes that were significantly regulated in sprouting neurons 
early after stroke, at day 7, as these are likely to be involved in the initiation of an axonal 
sprouting molecular program. Grouped by functional category, sprouting neurons in the 
young adult at day 7 regulate many GTPases, particularly in the RhoA and Ras pathways; 
axonal guidance genes; cytoskeletal modifying genes; and epigenetic or DNA-modifying 
genes (Table 1 and Supplementary Fig. 1). Many of the genes activated in sprouting neurons 
after stroke have been linked to axonal sprouting or axonal pathfinding in 
neurodevelopment, including MHC class I molecules, axonal guidance receptors such as 
neuropilin and L1 cell adhesion molecule (L1cam), complement (both C3 and C1 classes), 
and cytoskeletal modifying proteins such as stathmins (Stmn3 and Stmn4) (Table 1). 
However, stroke in young adults activated molecules that have not been linked to axonal 
sprouting previously, including epigenetic or DNA-modifying proteins such as histone 
deacetylase-4 (Hdac4), doublecortin-like kinases and several relatively uncharacterized 
GTPases (Table 1). Compared with the gene expression profile of sprouting neurons at day 7 
in the young adult, aged sprouting neurons showed a greater activation of immune-related 
genes, bone morphogenic family genes, insulin-like growth factor-1 (Igf1) and osteopontin 
(Spp1), and a distinct set of molecules that participate in axonal growth inhibition, including 
the receptor tyrosine kinase ephrin type-A receptor 4 (Epha4) and leucine rich repeat and Ig 
domain containing 1 (Lingo1) (Table 2 and Supplementary Fig. 1). Molecular pathway 
analysis identified several key signaling networks, from cell surface to nuclear proteins, in 
aged and young adult sprouting neurons (Supplementary Fig. 2 and Supplementary 
Discussion).
mRNA and Protein Confirmation of Induced Genes
We tested the expression profiles of a subset of the genes significantly regulated in the 
microarray studies with quantitative, real-time reverse-transcription(qRT)-PCR. Fourteen of 
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21 genes that were upregulated in aged sprouting neurons versus non-sprouting neurons at 
day 7 in the array data set were also upregulated by qRT-PCR: Alcam (activated leukocyte 
cell adhesion molecule), Atrx (α-thalassemia/mental retardation syndrome X-linked), 
Ceacm10 (carcinoembryonic antigen-related cell adhesion molecule 10), chimaerin-1 
(chimerin-1), Gdf10 (growth differentiation factor 10), Gpc3 (glypican-3), Igf1, Melk 
(maternal embryonic leucine zipper kinase), Nrxn1 (neurexin I), Sat2 (spermidine acetyl 
transferase, PRRX1 (Paired mesoderm homeobox protein 1), Spp1 (osteopontin), Svil 
(supervillin) and TPT1 (translationally-controlled tumor protein) (Table 2). This result is 
consistent with previous studies17. Igf1 and osteopontin were the most differentially 
regulated genes in aged sprouting neurons, with 20- and 12-fold induction compared to the 
control expression level of non-sprouting neurons.
To confirm the changes in gene expression from microarray studies, and to localize these to 
specific cells in peri-infarct cortex, we performed multilabel immunofluorescence studies at 
day 7 after stroke using both aged and young adult mice and testing protein products of 
genes significantly induced in aged sprouting neurons: ATRX, IGF1, Lingo1, GDF10 and 
osteopontin. ATRX immunoreactivity was present in similar intensity in neuronal nuclei in 
normal and young adult peri-infarct cortex (Fig. 2b,c), but had greater immunoreactivity in 
aged peri-infarct neurons (Fig. 2d and Supplementary Fig. 3n,o). After stroke, IGF1 was 
induced in glial fibrillary acidic protein (GFAP)-positive reactive astrocytes in peri-infarct 
cortex of the young adult18 (Fig. 2f and Supplementary Fig. 3i,j). Unexpectedly, stroke in 
aged mice induced IGF1 mostly in cells positive for the neuronal marker NeuN in peri-
infarct cortex (Fig. 2g and Supplementary Fig. 3d,e). Lingo1 immunoreactivity was stronger 
in NeuN-positive cells in aged peri-infarct cortex (Fig. 2j and Supplementary Fig. 3m,t) than 
in those in young adult (Fig. 2i) and control cortex (Fig. 2h). GDF10 localized to NeuN-
positive neurons in peri-infarct cortex and had greater staining intensity in aged peri-infarct 
neurons than in young adult peri-infarct neurons (Supplementary Figs. 3s and 4i,l). 
Osteopontin staining was present in the apical dendrites of neurons in control and peri-
infarct cortex and localized to cells positive for the microglial and macrophage marker Iba1; 
the intensity of immunoreactive staining was stronger in aged peri-infarct tissue than that in 
the young adult peri-infarct cortex (Supplementary Fig. 5). These data, together with the 
array and qRT-PCR studies, indicate that neurons upregulate ATRX, GDF10, Lingo1 and 
IGF1 in the aged brain after stroke more than they do in the young adult, and that IGF1 
induction after stroke switches from astrocytes in young adults to neurons in the aged brain.
ATRX mediates axonal sprouting after stroke
To identify the mechanistic roles of select members of this sprouting-related gene set, we 
tested the in vivo effect of gain or loss of function on connections in three systems that 
belong to distinct molecular groups: epigenetic DNA modification (ATRX), soluble growth 
factor (IGF1) and axonal growth inhibition (Nogo) systems. To determine the role of these 
three gene systems in axonal sprouting after stroke in vivo, we applied a quantitative 
connectional mapping technique to statistically compare the motor cortical connections of 
peri-infarct cortex in control, stroke and stroke plus gain- or loss-of-function conditions 
(Fig. 3 and Supplementary Discussion). In all experimental groups below, there was no 
difference in stroke size, tracer injection size or location (Supplementary Figs. 6 and 7).
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ATRX is an ATP-dependent DNA modifying enzyme that controls neuronal survival and 
migration during brain development19 but has not been implicated in axonal sprouting. Atrx 
small interfering RNA (Supplementary Fig. 9) was used to evaluate effects on axonal 
outgrowth in adult neurons. We used dorsal root ganglion neurons (DRG) to directly test the 
role of ATRX in axonal outgrowth because DRG neurons can be readily cultured from adult 
animals. ATRX knockdown with siRNA significantly but modestly inhibited axonal 
outgrowth of DRG neurons (P < 0.05 compared to scrambled control siRNA; Fig. 4a and 
Supplementary Fig. 9d). ATRX overexpression in adult rat DRG neurons promoted axonal 
outgrowth (P < 0.05 compared to the control; Fig. 4a and Supplementary Fig. 9e).
Axonal connections increased significantly within peri-infarct cortex after stroke in the 
normal stroke state and after scrambled siRNA delivery in mice (P < 0.05, Fig. 4e). Stroke 
alone significantly induced axonal sprouting in motor, premotor and somatosensory areas in 
peri-infarct cortex (Fig. 3d,e,g and Supplementary Discussion). This same pattern was seen 
upon scrambled siRNA delivery after stroke (Supplementary Fig. 8). ATRX knockdown in 
vivo after stroke blocked this post-stroke axonal sprouting response. There was a significant 
difference between the peri-infarct connections in stroke plus Atrx siRNA versus stroke plus 
scrambled siRNA (Fig. 4d,e), such that knockdown of ATRX produced a pattern of cortical 
connections in peri-infarct cortex that did not differ from the non-stroke (control) condition 
(Fig. 4e). Atrx siRNA infusion reduced slightly the number of axons that were labeled from 
forelimb motor cortex (Fig. 4b), indicating a possible role for this protein in the normal 
maintenance of cortical projections. Thus, stroke normally induces axonal sprouting in peri-
infarct cortex. ATRX induces axonal sprouting in vitro and is necessary for the normal 
process of post-stroke axonal sprouting in vivo.
IGF1 maintains cortical neurons after stroke
IGF1 has an established role in in vitro axonal outgrowth20 and in cortical development21. 
We delivered IGF1 within a biopolymer hydrogel from the infarct cavity, which produced 
sustained, local release of IGF1 over 4 weeks after implantation in vivo (Supplementary Fig. 
10b). Quantitative connectional mapping showed that stroke plus IGF1 at either high or low 
doses did not induce a statistically significant change in cortical connections compared to 
stroke plus vehicle (Fig. 5a,b). Unexpectedly, the IGF1 antagonist JB1(ref. 22) produced a 
significant reduction in the distribution of cortical connections from forelimb motor cortex 
to below the spatial extent that existed after stroke alone (Fig. 5c,d) and below the normal 
pattern of forelimb motor connections (Fig. 4e).
This collapse of cortical connections might occur because blockade of endogenous IGF1 
signaling after stroke causes a retraction in the axonal arbors of cortical neurons or causes 
cell death23,24. JB1 delivery beginning 7 d after stroke produced significant neuronal cell 
death in peri-infarct cortex (Fig. 5). IGF1 delivery at this late stage after stroke did not affect 
neuronal number (Fig. 5e). IGF1 or JB1 delivery in the normal, non-stroke condition did not 
have any effect on neuronal cell number (Fig. 5f). Thus, stroke induces an unexpected and 
delayed neuronal dependency on IGF1 signaling for survival at periods of time well after the 
acute ischemic stimulus is over.
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Nogo receptor complex-1 signaling restricts axonal sprouting after stroke
We mapped cortical connections following delivery of a Lingo1 function-blocking protein 
(Lingo1-Fc)25 and in Nogo receptor complex-1 (NgR1, Rtn4r, reticulon 4 receptor) 
knockout mice. In addition to the upregulation of Lingo1 after stroke in aged adults (Fig. 2d 
and Table 2), myelin-associated glycoprotein (MAG), a ligand for NgR1, NgR2, and 
PirB26,27, was also uniquely induced in the aged brain after stroke13. Because NgR2 
(Rtn4rl2, reticulon 4 receptor-like 2) is a receptor selective for MAG, we also mapped the 
cortical connections of NgR2 knockout mice (Supplementary Fig. 12e).
Blockade of Lingo1 produced a significant induction in post-stroke axonal sprouting (P < 
0.05, compared to control immunoglobulin G Fc, Fig. 6a–c), inducing new patterns of 
connections in premotor and motor cortex and in primary and secondary somatosensory 
areas (P < 0.001, Fig. 6b). There was also a significant increase in axonal connections in the 
NgR1 knockout after stroke, with a distribution of new axonal connections that is similar to 
that seen with Lingo1 blocakde(P < 0.05 compared to saline stroke, Fig. 6d–f). There was no 
significant difference in axonal sprouting between NgR2 knockout stroke and saline stroke 
groups (P > 0.05, Supplementary Fig. 12d). There was no difference in the pattern of 
connections from forelimb motor cortex between NgR1 and NgR2 knockout mice and 
C57BL/6 mice in non-stroke conditions (Supplementary Fig. 12a–c).
DISCUSSION
Cortical plasticity after stroke is associated with recovery. Neurons in the peri-infarct region 
sprout new connections2,3. Cortical connections are normally show minimal overall change 
over the course of months in dendritic spines or axonal terminals even in the presence of 
sensory deprivation28,29. Axonal sprouting after stroke thus represents a phenotypic 
response to central injury: an adult neuron forms new connections within an environment 
that normally restricts this process. Here we have used a sequential tracer approach to 
selectively identify the gene expression profile of sprouting neurons after stroke in young 
and aged adults. Cortical neurons that sprouted after stroke activated a distinct gene 
expression profile, or ‘sprouting transcriptome’, which differed markedly in aged versus 
young adult sprouting neurons. Mechanistic studies of molecules in three distinct functional 
classes of this cortical sprouting transcriptome identified a new epigenetic regulatory protein 
in axonal sprouting after stroke, an unexpected growth factor dependency in the adult cortex 
after stroke and a paradoxical upregulation of inhibitory myelin receptors after stroke in 
aged neurons that limits axonal sprouting.
Sprouting transcriptome in cortical neurons after stroke
Sprouting neurons activated a distinct sprouting transcriptome that included both newly 
identified and established growth-associated genes. Sprouting neurons regulated axonal 
guidance molecules, including downregulating L1CAM and upregulating neuropilin-1, the 
structurally related molecule NETO2 and several MHC1 class I and complement genes. 
Neuropilin-1 transduces the growth cone–collapsing signals of semaphorin 3a, but also the 
axonal outgrowth–promoting signals of vascular endothelial growth factor (VEGF)30. Stroke 
induces both semaphorin 3a14 and VEGF31 within the region of sprouting neurons after 
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stroke, placing both ligands near sprouting neurons with this induced neuropilin-1 receptor. 
MHC class I molecules have a role in activity-dependent axonal remodeling in the 
developing and adult brain, where they control topographic mapping in the retino-geniculate 
system and ocular dominance plasticity in visual cortex8. Other immune molecules also 
function in synaptic remodeling during development, including the complement proteins C3 
and C1q32. C1q is activated in retinal ganglion8 and facial motor neurons33 during axonal 
sprouting, but not in sprouting neurons in cortex after stroke, pointing up differences in 
these cell populations during axonal regeneration. MHC class I and complement molecules 
provide a signal for synaptic elimination in development but may have a permissive role for 
axonal sprouting in adult CNS injury34.
Sprouting neurons activate many genes with a role in cytoskeletal modification, cell-cell 
adhesion and extracellular matrix interactions. In general, these gene products promote actin 
or microtubule cytoskeletal changes associated with cell migration or axonal outgrowth in 
development, and are likely to act similarly in the subcellular remodeling that occurs in 
sprouting neurons in peri-infarct cortex after stroke. Actin-related protein 2/3, destrin, 
cortactin, kelch domain containing-3, α-dystrobrevin and supervillin all interact with actin to 
influence actin cytoskeletal turnover, actin interactions with cell adhesion signals, or actin-
associated motility. Integrin and integrin signaling molecules, induced in sprouting neurons 
after stroke, link extracellular matrix binding events to actin cytoskeleton remodeling and 
axonal outgrowth35,36. Sprouting neurons induce microtubule-modifying genes (Table 1), 
notably microtubule-associated protein 4, the neuronal polarity molecule tyrosine ligase-like 
family member 7 (TTLL7), stathmins and doublecortin-motif proteins. Stathmin-family 
proteins promote a more dynamic cytoskeletal structure that provides outgrowth10,37. TTL7 
polyglutamylates tubulin and promotes neurite outgrowth38. In sprouting neurons many of 
these genes are associated with larger molecular systems, in which functionally related 
cytoskeleton-modifying or cell adhesion molecules are co-regulated in systems of molecular 
pathways with molecules such as small GTPases, amyloid-β precursor protein (APP), 
kinesins, growth factors and transcription factorsvfrom the cell surface to the nucleus 
(Supplementary Figs. 1 and 2 and Supplementary Discussion). Some of the components of 
this sprouting neuron cytoskeletal network resemble those seen in growth cone proteomic 
screens36 and in peripheral nerve regeneration after injury10. These data suggest that a 
sprouting or regeneration transcriptome after stroke involves a coordinated regulation in 
gene expression that underlies a switch in cellular phenotype toward a state of active 
neuronal outgrowth within the adult brain environment.
Sprouting neurons from the peri-infarct cortex of aged animals had a transcriptional profile 
that differed in key molecular classes from that of young adult sprouting neurons, 
particularly in cytokine and chemokine, axonal guidance, bone morphogenic protein, cell 
adhesion and growth factor molecules (Table 2 and Supplementary Discussion). Aged 
sprouting neurons paradoxically upregulate, EphA4 and Lingo1, receptors for axonal growth 
inhibitory proteins. In addition to the cell surface receptor EphA4, a downstream mediator of 
EphA4 signaling, the Rho-GAP chimerin-1 (ref. 39), is also induced in aged sprouting 
neurons. Lingo1 is part of the Nogo receptor-1 complex and is associated with inhibition of 
axonal sprouting in spinal cord injury and in saxonal sprouting after that occurs into the 
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spinal cord5,40. These data suggest that a reduced recovery in aged stroke may relate to 
increased axonal growth inhibition directly in sprouting neurons in the aged peri-infarct 
brain. Not only did the absolute levels of specific molecules differ between aged and young 
adult sprouting neurons, but the cellular expression profile also was distinct, with IGF1 
induction in peri-infarct astrocytes in the young adult (Fig. 2f) but in peri-infarct neurons in 
the aged adult (Fig. 2g). Gene products that are involved in DNA epigenetic or structural 
regulation were upregulated in both aged and young adult, and differed by age (Table 2). 
Epigenetic control of DNA structure and gene expression has a prominent role in brain 
development and neural stem cell differentiation41 and may influence the phenotypic change 
characterized by post-stroke axonal sprouting. ATRX was one of the most highly induced 
genes in aged sprouting neurons after stroke, and it was also upregulated in young adult 
sprouting neurons, but this upregulation, at P = 0.036, fell short of the statistical cutoff (P ≤ 
0.005) established in this data set.
Growth factor dependence, epigenetic modifiers and growth inhibitors after stroke
Stroke itself induces axonal sprouting within motor and somatosensory areas of peri-infarct 
cortex (Supplementary Discussion) both locally and up to several millimeters away from the 
infarct. Knockdown of ATRX expression blocked post-stroke axonal sprouting. This 
establishes a direct role for stroke-induced neuronal ATRX expression in the process of 
post-stroke axonal sprouting. IGF1 delivery did not induce any significant change in motor 
cortical connections above the normal degree of post-stroke axonal sprouting. This result 
was unexpected, as IGF1 mediates axonal sprouting from cortical neurons in development21 
and acts in axonal and dendritic remodeling in many systems20. One possible explanation 
might be that IGF1 is at a biological maximum after stroke, with increases already at 3 d 
after stroke (Supplementary Fig. 10a). However blockade of IGF1, induced 1 week after 
stroke, produced widespread neuronal cell death in peri-infarct cortex and a contraction in 
the pattern of intracortical connections. One week after stroke is a time period in which the 
initial injury from stroke is long past; most cell death ceases within 3 d in this and other 
experimental models of stroke42. The death of neurons when IGF1 signaling was locally 
blocked late after stroke suggests a delayed neuronal growth factor dependency in peri-
infarct cortex long after the stroke stimulus. Because the amount of neuronal cell death does 
not differ between aged and young adults in stroke13, it is possible that the upregulation of 
IGF1 in the aged brain functions to support peri-infarct neurons and limit a progressive 
neuronal cell death. Blockade of Lingo1 and knockout of its receptor partner NgR1 
enhanced post-stroke axonal sprouting in motor cortex. These data indicate that the NgR1–
Lingo1–Troy–p75 signaling system is critical for normally limiting post-stroke axonal 
sprouting in peri-infarct cortex, as it does in contralateral cortex after stroke8,42, but extends 
this concept to indicate that sprouting neurons in the aged brain upregulate a myelin protein 
receptor.
These results indicate a widespread cellular and molecular alteration in peri-infarct cortex 
after stroke. This tissue survives the stroke and appears morphologically intact to gross 
histological examination in both humans and experimental animals. However, neurons in 
this region are not static survivors of cerebral ischemia: they are induced to express an age-
related growth-associated genetic program that controls axonal sprouting and mediates the 
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formation of new patterns of connections within the sensorimotor system. Axonal sprouting 
or regeneration after stroke thus resembles a neurodevelopmental cellular program: a 
specific molecular program mediates formation of new axonal connections in neurons which 
require a growth factor for their survival.
METHODS
Methods and any associated references are available in the online version of the paper at 
http://www.nature.com/natureneuroscience/.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Experimental approach and laser capture microdissection of sprouting neurons after stroke. 
(a) Stroke was produced by permanently occluding two anterior branches of the distal 
middle cerebral artery over the parietal cortex and transiently occluding bilateral jugular 
veins. Two different fluorescent conjugates of the tracer cholera toxin B subunit (CTB) were 
sequentially injected into the same site of forelimb sensorimotor cortex, the first at the time 
of stroke (Alexa 488–CTB) and the second at 2/3 the volume either 7 or 21 d after stroke 
(Alexa 647–CTB). Neurons that project to this forelimb sensorimotor site at the time of 
stroke are labeled with Alexa 488–CTB; neurons that establish a projection to this site only 
after stroke are labeled solely with Alexa 647–CTB. (b) Injection sites from three separate 
cases. Only mice in which the second tracer injection was entirely within the first were used 
for further analysis. (c) Young adult sprouting neurons are shown in the top row and 
sprouting neurons from an aged brain are shown in the bottom row. The left column shows 
neurons labeled by the first tracer injection; the middle column neurons labeled by the 
second tracer injection; the right column neurons seen after laser capture of a tracer 2-only 
neuron. Neurons with double label (non-sprouting neurons; arrowheads) or labeled by CTB-
Alexa 647( tracer-2 only, sprouting neurons; arrows) were separately laser-captured in the 
peri-infarct cortex. Scale bars, 50 μm (c) and 10 μm (b).
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Figure 2. 
Cellular pattern of ATRX, IGF1 and Lingo1 expression in the brain after stroke. (a) Nissl-
stained photomicrograph of mouse barrel field stroke model. Boxes indicate region of 
contralateral cortex (left column) and peri-infarct cortex in young adult (middle column) and 
aged adult (right column). (b–j) Panels for ATRX (b–d), IGF1 (e–g) and Lingo1 (h–j) show 
immunoreactivity in each condition. Insets: Colocalized staining of ATRX (red) and NeuN 
(green) is seen as yellow (d). IGF1 staining (red) localizes to astrocytes and not neurons 
(green) in young adult peri-infarct cortex (f). In aged adult peri-infarct cortex, IGF1 (red) 
co-localizes to NeuN positive neurons (green) (g). Lingo1 staining (red) localizes to NeuN 
positive neurons (green) in aged peri-infarct cortex (j). Scale bars, 1 mm (a), 50 μm (b–d) 
and 20 μm (insets).
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Figure 3. 
Quantitative connectional mapping. (a) Timeline of experimental design for all in vivo 
axonal tracer experiments. Mice received a sham surgery or stroke, followed 1 week later by 
siRNA or drug delivery. Three weeks later biotinylated dextran amine (BDA) was 
microinjected into forelimb motor cortex. (b,c) The cortex was then removed, flattened, 
tangentially cut (b) and stained for cytochrome oxidase (c) and BDA in the same sections. 
(d,e)The location of BDA-labeled axons was digitally mapped in x, y coordinates relative to 
the injection site. (d) The quantitative connectional map of forelimb sensorimotor 
connections in sham-operated animals (n = 5). (e) The quantitative connectional map of 
forelimb sensorimotor cortex connections after stroke (n = 7). (f) Cytochrome oxidase 
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staining in layer IV identifies the mouse somatosensory body map2 after stroke. (g) Each 
connectional map was registered to the somatosensory body map from the same brain to 
produce a group connectional and functional map of cortex. Axonal sprouting was identified 
when a pattern of cortical connections was precisely mapped and statistically different 
across treatment conditions. Scale bars, 1 mm.
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Figure 4. 
ATRX function in post-stroke axonal sprouting. (a) Knockdown of ATRX by siRNA 
reduced axonal outgrowth in vitro compared to scrambled siRNA treatment. ATRX 
overexpression induced axonal sprouting compared to expression of GFP alone. (b) Axon 
numbers in normal control or peri-infarct cortex layer 2/3 with Atrx siRNA or scrambled 
siRNA. (c) Sham, non stroke forelimb motor cortex connections (blue, n = 10) compared to 
those from Atrx siRNA siRNA group (red, n = 12). The blue label indicates the position of 
axons projecting from motor cortex summed from the entire sample of mice in the sham, 
non-stroke condition. The red label indicates that position of axons from the entire sample of 
mice treated with Atrx siRNA. The dark blue is the areas of dense overlap of the two 
projection systems. There was no significant difference in the pattern of cortical connections 
between normal (non-stroke, sham operated (d) Quantitative connectional map of forelimb 
sensorimotor connections in stroke + scrambled siRNA (blue, n = 11) and stroke + ATRX 
siRNA (red, n = 12), registered to the body map of underlying cortex with stroke. Dark blue 
shows area of dense overlap of connections in the two conditions. There is a significant 
increase in motor cortex projections between stroke + scrambled siRNA and stroke + ATRX 
siRNA. (e) Polar plots of axonal label from studies in (d). Shaded regions represent 70th 
percentile of the distances of labeled axons from the injection site; weighted polar vectors 
represent the normalized distribution of the number of points in a given segment of the 
graph. There was a significant difference in distribution of cortical projections between 
stroke + Atrx siRNA (red) and stroke + scrambled siRNA (blue) and between stroke + 
scrambled siRNA (blue) and non-stroke vehicle (yellow), and no significant change between 
stroke + Atrx siRNA (red) and non-stroke vehicle (yellow) (n = 10, P > 0.05). Scale bars, 1 
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mm. Error bars, s.d.; @, * and ** indicate a significant difference compared to saline normal 
control, GFP control and scrambled siRNA stroke, respectively.
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Figure 5. 
IGF1 maintains neuronal viability after stroke. (a) There was no significant difference in the 
pattern of cortical connections between stroke + saline (n = 5) and stroke + IGF1 (n = 7). (b) 
There was no significant change in the polar distribution of connections with IGF1 
administration compared to stroke + saline (P > 0.05). (c) There was a significant loss of 
cortical connections between stroke + saline (n = 5) and stroke + JB1 (n = 8). (d) There was 
a significant decrease in polar distribution of connections with IGF1 blockade (P < 0.001). 
(e) Photomicrographs of neurons in peri-infarct cortex, showing no change in number across 
IGF1 treatment conditions. (f) (f) Effects of IGF1 and JB1 on neuronal number in layer 5 in 
normal control or peri-infarct cortex. IGF1 or JB1 were delivered beginning 7 days after 
stroke. Stroke (n = 6) induces neuronal cell death in peri-infarct cortex (p < 0.01). This 
neuronal death is not altered by delivery of IGF1 (n = 5, p > 0.05) or vehicle (n = 5, p > 
0.05) into peri-infarct cortex. However, IGF1 blockade with JB1 + hydrogel significantly (n 
= 5, p < 0.05) increases cell death in peri-infarct cortex when compared to the saline + 
hydrogel (n = 5) –treated animals post-stroke. (g) Photomicrographs of neurons in peri-
infarct cortex, showing decrease in number of neurons with JB1-induced IGF1 signaling 
blockade. Scale bars, 500 μm (c,g) and 1 mm (a,b,d,e). Note that the location of BDA tracer 
injection was more lateral in ATRX studies (Fig. 4) than in IGF1/JB1 and Lingo1-Fc/NgR1/
NgR2 studies, the latter two of which use the same tracer coordinates; this produces slightly 
different patterns of intracortical connections. Error bars, s.d, *** p < 0.001 and ** p < 0.01 
indicate a significant difference compared to normal control; # < 0.05 indicates a significant 
difference compared to stroke saline + hydrogel.
Li et al. Page 18
Nat Neurosci. Author manuscript; available in PMC 2011 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 6. 
Lingo1/NgR1 restricts cortical axonal sprouting after stroke. Quantitative connectional maps 
of forelimb motor connections with NgR1 signaling blockade after hydrogel delivery of 
Lingo1-Fc + stroke (n = 6) versus hydrogel control-Fc + stroke (n = 7). (a) Lingo1-Fc 
release into peri-infarct cortex induced a significantly different pattern of forelimb motor 
cortex connections. (b) Registration of motor cortical connections with the underlying 
cytochrome oxidase body map shows that Lingo1-Fc blocked the connections that form 
lateral and rostral to mouse somatosensory cortex, in secondary somatosensory cortex and 
motor cortex. (c) Polar analysis of forelimb sensorimotor connections from same maps. 
Lingo1-Fc induced a significant increase in motor cortex connections in the sites seen in the 
body map registration motor cortex, SI and SII (P < 0.001). (d). Quantitative connectional 
map of forelimb sensorimotor connections in NgR1 knockout mice with stroke (n = 5) 
versus control mouse stroke (n = 5). There was a significant increase in the pattern of 
cortical connections in NgR1 knockout. (e) Registering the underlying mouse body map to 
the motor cortical projections indicates that new projections could be seen in the NgR1 
knockout in lateral SI, SII and to a lesser extent in motor cortex. (f) Polar analysis of 
forelimb motor connections in stroke + NgR1 knockout versus control. Significantly 
different connections were seen in motor and lateral somatosensory regions (P < 0.005). 
Scale bars, 1 mm.
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Table 2
Genes differentially regulated in sprouting neurons at day 7 in aged adult vs. young adult
Chemokines/Cytokines
Mip1a/CCL3
Mip1b/CCL4
Mip2/CXCL2
Interleukin 1 receptor antagonist
IL-27
Bone morphogenic proteins
Growth differentiation factor 10
ONECUT2
Bone morphogenic protein 1
Cytoskeletal proteins
Filamin A interacting protein
Supervillin
Actin related protein 2/3 complex, subunit 5-like
Actin-related protein 2
Tyrosine ligase-like family member 7, transcript variant 2
Cofilin 1
Plastin 3 (down)
Calsyntenin (down)
Neurofilament heavy chain (down)
Alpha catenin (down)
Synaptogenesis Proteins
Piccolo
Synaptotagmin 1
Synaptic vesicle glycoprotein 2b
Synaptophysin (down)
Protocadherin X
Adhesion molecules
Osteopontin
BEN/Alcam/CD166/Sc1
Glypican 3
CEA-related cell adhesion molecule 10
Neurexin 1
Cadherin 8
Polyamine pathway
Spermidine/spermine N1-acetyl transferase
Arginase II (down)
Growth Factors
IGF-1
Epidermal growth factor receptor (Egfr)
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Glial cell line derived neurotrophic factor family receptor
alpha 3
SORCS3
Axonal Guidance
EphA4
Lingo-1
Kinases/Signaling Enzymes
PKCdeleta
Phospholipase C, gamma 2 (Plcg2)
Regucalcin (down)
Neuronal plasticity
Homer (down)
ARC (down)
Epigenetic or DNA modifying
ATRX
HDAC11
Transcription Factors
Prrx1
Lim Homeobox 9
B cell translocation gene 1
Janus kinase 1, Janus kinase 2
Ring finger protein 29 (Rnf29)
Zinc finger protein 560
E2F transcription factor 1 (E2f1)
General transcription factor IIa 2 (Gtf2a2)
Recombining binding protein suppressor of hairless
Egr1 (down)
Neuron-derived orphan receptor 1 (down)
Atf5 (down)
GTPases
Sec5l1
Chimaerin 1
Rho GDP dissociation inhibitor (GDI) alpha
Rho, GDP dissociation inhibitor (GDI) beta
Guanylate cyclase 1, soluble, alpha 3
Mas1 oncogene (down)
Rab2b (down)
Immune Related
Toll-like receptor 2
CD86
Interferon gamma receptor 2
MHC1RT1 class Ib_ locus S3 (RT1-S3) (down)
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